市場調査レポート
商品コード
1055763

超音波の世界市場:技術別(診断用、治療用)、ディスプレイ別(カラー、白黒)、可搬性別(トロリー、POC)、用途別(婦人科、循環器科、整形外科)、コンポーネント別(プローブ)、エンドユーザー別(病院)- 2026年までの予測

Ultrasound Market by Technology (Diagnostic (2D, 3D, Doppler), Therapeutic (HIFU, ESWL)), Display(Color, B&W), Portability (Trolley, POC), Application(Gynecology, Cardiology, Orthopedic), Component(Probe), End user (Hospitals) - Global Forecasts -2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 270 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
超音波の世界市場:技術別(診断用、治療用)、ディスプレイ別(カラー、白黒)、可搬性別(トロリー、POC)、用途別(婦人科、循環器科、整形外科)、コンポーネント別(プローブ)、エンドユーザー別(病院)- 2026年までの予測
出版日: 2022年01月24日
発行: MarketsandMarkets
ページ情報: 英文 270 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の超音波の市場規模は、予測期間中に6.3%のCAGRで推移し、2021年の67億米ドルから、2026年には90億米ドルに達すると予測されています。

同市場の成長は主に、技術進歩、対象疾患の発生率の増加、低侵襲手術に対する患者の選好の高まり、公共・民間の投資、資金調達、助成金の増加などに起因しています。ただし、政府の厳しい規制が、今後数年間の同市場の成長を抑制する可能性があります。

地域別では、アジア太平洋が予測期間中に最も高いCAGRで成長すると予測されています。同地域の主要国(特にインドと中国)における医療費支出の増加、治療効果に対する一般市民の認識の高まり、継続的な装置コストの低下、対象疾患の有病率上昇などが成長を促進する要因に挙げられます。

当レポートでは、世界の超音波市場について調査し、市場力学、価格動向、規制や特許、セグメント・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 超音波市場概要
  • タイプ・国別:欧州の診断用超音波市場
  • 用途別:超音波市場(2021 VS 2026、金額)
  • 超音波市場の地理的スナップショット

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • 動向
  • 価格動向分析(2017-2020)
  • バリューチェーン分析
  • 規制分析
  • ポーターのファイブフォース分析
  • 超音波市場へのCOVID-19の影響
  • エコシステムの範囲:超音波市場
  • 特許分析
  • 超音波システムの貿易分析

第6章 技術別:超音波市場

  • 診断用超音波
    • 診断用超音波市場
    • 2D超音波
    • 3Dおよび4D超音波
    • ドップラー超音波
  • 治療用超音波
    • 治療用超音波市場
    • 体外衝撃波結石術
    • 高密度焦点式超音波

第7章 システム可搬性別:超音波市場

  • トロリー/カートベースデバイス
  • コンパクト/テーブルトップデバイス
  • POC/ポータブルデバイス

第8章 ディスプレイタイプ別:超音波市場

  • カラー超音波装置
  • 白黒超音波装置

第9章 用途別:超音波市場

  • 放射線/一般イメージング
  • 循環器
  • 産科/婦人科
  • 血管
  • 泌尿器科
  • 整形外科および筋骨格系
  • 疼痛管理
  • その他

第10章 コンポーネント別:超音波市場

  • トランスデューサー/プローブ
    • 曲線/凸配列プローブ
    • ライナーアレイプローブ
    • フェーズドアレイプローブ
    • その他
  • ワークステーション
  • その他

第11章 エンドユーザー別:超音波市場

  • 病院・外科センター・診断センター
  • マタニティセンター
  • 外来ケアセンター
  • 研究・学術機関
  • その他

第12章 地域別:超音波市場

  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ
  • 中東・アフリカ

第13章 競合情勢

  • 概要
  • 主要企業の戦略
  • レベニューシェア分析
  • 市場シェア分析:主要企業別の超音波市場(2020)
  • 主要企業25社の企業評価クアドラント(2020)
  • スタートアップ/中小企業の企業評価クアドラント(2020)
  • 競合ベンチマーキング
  • 競合シナリオ(2018-2021)

第14章 企業プロファイル

  • 主要企業
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS N.V.
    • CANON MEDICAL SYSTEMS CORPORATION
    • SIEMENS AG
    • HITACHI, LTD.
    • HOLOGIC, INC.
    • FUJIFILM HOLDINGS CORPORATION
    • SAMSUNG ELECTRONICS CO., LTD.
    • MINDRAY MEDICAL INTERNATIONAL LIMITED
    • ANALOGIC CORPORATION
    • ESAOTE SPA
    • CARESTREAM HEALTH
    • CURA HEALTHCARE
    • CHISON MEDICAL TECHNOLOGIES CO., LTD.
  • その他の企業
    • MOBISANTE, INC.
    • NEUSOFT CORPORATION
    • CLARIUS MOBILE HEALTH
    • MEDGYN PRODUCTS, INC.
    • UNITED IMAGING HEALTHCARE CO., LTD.
    • PROMED TECHNOLOGY CO., LTD.
    • CEPHASONICS
    • UAB TELEMED
    • SHENZHEN RICSO TECHNOLOGY CO., LTD.
    • WUHAN YOUKEY BIO-MEDICAL ELECTRONICS CO., LTD.

第15章 付録

目次
Product Code: MD 2885

The global ultrasound market is projected to reach USD 9.0 billion by 2026 from USD 6.7 billion in 2021, at a CAGR of 6.3% during the forecast period. Growth of the market is mainly attributed to the technological advancements; increasing incidences of target diseases; rising patient preference for minimally invasive procedures; and growing public and private investments, funding, and grants are driving the growth of the global ultrasound market. However, stringent government regulations may restrict the growth of this market to a certain extent in the coming years.

"therapeutic ultrasound technology segment to register significant growth, during the forecast period"

On the basis of technology, the ultrasound market is segmented into diagnostic ultrasound and therapeutic ultrasound devices. The therapeutic ultrasound segment is expected to grow at a significant rate over the forecast period. Therapeutic ultrasound technologies include focused ultrasound and shockwave lithotripsy. The growth of this market is driven mainly by ongoing technological innovations in the field of focused ultrasound as well as the expansion of its application horizons.

"Color ultrasound devices segment is expected to witness the highest growth in the ultrasound market, by device display, during the forecast period"

On the basis of device display, the ultrasound market is segmented into black & white ultrasound and color ultrasound devices. The color ultrasound devices segment is expected to grow at the highest CAGR during the forecast period owing to the benefits offered by these devices, such as better image quality and higher image resolution. Also, the growing availability of advanced color ultrasound devices, coupled with the continuous decline in product cost across major countries and expanding distribution networks of major manufacturers across emerging countries, are expected to support the growth of this market segment during the forecast period.

"Trolley/cart-based ultrasound systems segment is expected to account for the largest share of the ultrasound market, by system portability"

Based on system portability, the ultrasound market is segmented into trolley/cart-based ultrasound systems, compact/handheld ultrasound systems, and point-of-care (PoC) ultrasound systems. In 2020, the trolley/cart-based ultrasound systems segment is expected to account for the largest market share due to the growing adoption of these systems across major markets (as a result of their increasing use in emergency care and acute care settings in hospitals and healthcare institutions).

"Transducers/ Probes segment is expected to account for the largest share in the Component segment in 2021"

On the basis of component, the ultrasound market is segmented into transducers/probes, workstations, and other components. The transducers/probes segment is further divided into curvilinear/convex array probes, liner array probes, phased array probes, and other probes. The transducers/probes segment accounted for the largest share of the ultrasound market in 2020. This can be attributed to technological advancements, the introduction of specially designed products, and the rising adoption of ultrasound technology for the diagnosis of various disease indications.

"Asia Pacific market is expected to grow at the highest CAGR during the forecast period"

The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the increasing healthcare expenditure across the region's major countries (especially India and China), growing public awareness about the therapeutic potential of ultrasound technologies, continuous decrease in device costs (due to growing localized manufacturing and the presence of global market players), rising prevalence of target diseases, and the ongoing trend of device miniaturization.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-45%, Tier 2-34%, and Tier 3- 21%
  • By Designation: C-level-47%, Director-level-33%, and Others-20%
  • By Region: North America-35%, Europe-32%, Asia Pacific-25%, Latin America-6%, and the Middle East & Africa-2%

In 2020, the ultrasound market was dominated by GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Hitachi, Ltd. (Japan), and Siemens Healthineers AG (Germany).

Research Coverage

This report studies the ultrasound market based on technology, device display, system portability, application, component, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the ultrasound market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the ultrasound market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the ultrasound market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY USED FOR THE STUDY
  • 1.5 MARKET STAKEHOLDERS
  • 1.6 LIMITATIONS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.2.1 VENDOR REVENUE-BASED MARKET SIZE ESTIMATION
    • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
    • 2.2.2 END USER-BASED MARKET SIZE ESTIMATION
    • FIGURE 5 ULTRASOUND MARKET: END USER-BASED ESTIMATION
    • 2.2.3 PRIMARY RESEARCH VALIDATION
  • 2.3 COVID-19 HEALTH ASSESSMENT
  • 2.4 COVID-19 ECONOMIC ASSESSMENT
  • 2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.6 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.7 RESEARCH ASSUMPTIONS
  • 2.8 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

    • FIGURE 9 ULTRASOUND MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 ULTRASOUND MARKET SHARE, BY DISPLAY TYPE, 2021 VS. 2026
    • FIGURE 11 ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 ULTRASOUND MARKET SHARE, BY END USER, 2021 VS. 2026
    • FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE ULTRASOUND MARKET

4 PREMIUM INSIGHTS

  • 4.1 ULTRASOUND MARKET OVERVIEW
    • FIGURE 15 TECHNOLOGICAL ADVANCEMENTS AND INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE THE GROWTH OF THE ULTRASOUND MARKET
  • 4.2 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE AND COUNTRY
    • FIGURE 16 GERMANY IS THE LARGEST MARKET FOR DIAGNOSTIC ULTRASOUND IN EUROPE
  • 4.3 ULTRASOUND MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 17 VASCULAR APPLICATIONS SEGMENT TO REGISTER SUBSTANTIAL GROWTH IN THE GLOBAL ULTRASOUND MARKET
  • 4.4 GEOGRAPHIC SNAPSHOT OF THE ULTRASOUND MARKET
    • FIGURE 18 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 19 ULTRASOUND MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of target diseases
      • 5.2.1.2 Rising patient preference for minimally invasive procedures
      • 5.2.1.3 Technological advancements
    • TABLE 1 RECENT PRODUCT LAUNCHES/APPROVALS IN THE ULTRASOUND MARKET
      • 5.2.1.4 Growing public and private investments, funding, and grants
      • 5.2.1.5 Increasing number of diagnostic centers & hospitals
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Unfavorable healthcare reforms in the US
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Expanding applications of therapeutic ultrasound
      • 5.2.3.2 Emerging markets
      • 5.2.3.3 Development of POC ultrasound devices
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Growing end-user preference for refurbished equipment
      • 5.2.4.2 Dearth of skilled and well-trained sonographers
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 DEVELOPMENT OF APPLICATION-SPECIFIC ULTRASOUND DEVICES
    • 5.3.2 GROWING USE OF ULTRASOUND IN ELASTOGRAPHY
    • 5.3.3 INCREASING USE OF MR-GUIDED ULTRASOUND MODALITIES IN NEUROLOGY APPLICATIONS
  • 5.4 PRICING TREND ANALYSIS (2017-2020)
    • 5.4.1 NORTH AMERICA
    • 5.4.2 EUROPE
    • 5.4.3 ASIA PACIFIC
    • 5.4.4 REST OF THE WORLD
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 20 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING THE MANUFACTURING PHASE
  • 5.6 REGULATORY ANALYSIS
    • 5.6.1 NORTH AMERICA
      • 5.6.1.1 US
    • TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.6.1.2 Canada
    • TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 21 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.6.2 EUROPE
    • FIGURE 22 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
    • 5.6.3 ASIA PACIFIC
      • 5.6.3.1 Japan
    • TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.6.3.2 China
    • TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.6.3.3 India
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 7 ULTRASOUND MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 DEGREE OF COMPETITION
  • 5.8 COVID-19 IMPACT ON THE ULTRASOUND MARKET
  • 5.9 ECOSYSTEM COVERAGE: ULTRASOUND MARKET
  • 5.10 PATENT ANALYSIS
    • FIGURE 23 TOP 10 PATENT APPLICANTS FOR ULTRASOUND (DECEMBER 2021)
    • FIGURE 24 PATENT APPLICATIONS FOR ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
    • FIGURE 25 TOP 10 PATENT APPLICANTS FOR THERAPEUTIC ULTRASOUND (JANUARY 2011 TO AUGUST 2021)
    • FIGURE 26 PATENT APPLICATIONS FOR THERAPEUTIC ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
    • FIGURE 27 TOP 10 PATENT APPLICANTS FOR POINT-OF-CARE ULTRASOUND (JANUARY 2011 TO AUGUST 2021)
    • FIGURE 28 PATENT APPLICATIONS FOR POINT-OF-CARE ULTRASOUND (JANUARY 2011 TO DECEMBER 2021)
  • 5.11 TRADE ANALYSIS FOR ULTRASOUND SYSTEMS
    • TABLE 8 IMPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 9 EXPORT DATA FOR ULTRASOUND SYSTEMS, BY COUNTRY, 2016-2020 (USD MILLION)

6 ULTRASOUND MARKET, BY TECHNOLOGY

  • 6.1 INTRODUCTION
    • TABLE 10 ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
  • 6.2 DIAGNOSTIC ULTRASOUND
    • TABLE 11 DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 12 DIAGNOSTIC ULTRASOUND MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.1 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 13 DIAGNOSTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • 6.2.2 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 14 DIAGNOSTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • 6.2.3 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 15 DIAGNOSTIC ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 6.2.4 DIAGNOSTIC ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 16 DIAGNOSTIC ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.5 2D ULTRASOUND
      • 6.2.5.1 Strong market demand from less-developed and emerging countries to sustain the growth of this segment
    • TABLE 17 2D ULTRASOUND MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.6 2D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 18 2D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • 6.2.7 2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 19 2D ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • 6.2.8 2D ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 20 2D ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 6.2.9 2D ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 21 2D ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.10 3D AND 4D ULTRASOUND
      • 6.2.10.1 Greater diagnostic accuracy and improved imaging capabilities to boost the global market demand for 3D/4D ultrasound
    • TABLE 22 3D AND 4D ULTRASOUND MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.11 3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 23 3D AND 4D ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • 6.2.12 3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 24 3D AND 4D ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • 6.2.13 3D AND 4D ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 25 3D AND 4D ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 6.2.14 3D AND 4D ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 26 3D AND 4D ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.2.15 DOPPLER ULTRASOUND
      • 6.2.15.1 Growing application in pain management, cardiovascular imaging, and emergency care to drive market growth
    • TABLE 27 DOPPLER ULTRASOUND MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.16 DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 28 DOPPLER ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • 6.2.17 DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 29 DOPPLER ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • 6.2.18 DOPPLER ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 30 DOPPLER ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 6.2.19 DOPPLER ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 31 DOPPLER ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 6.3 THERAPEUTIC ULTRASOUND
    • TABLE 32 THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 33 THERAPEUTIC ULTRASOUND MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.1 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 34 THERAPEUTIC ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • 6.3.2 THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 35 THERAPEUTIC ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • 6.3.3 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 36 THERAPEUTIC ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 6.3.4 THERAPEUTIC ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 37 THERAPEUTIC ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.3.5 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY
      • 6.3.5.1 Growing emphasis on the minimally invasive treatment of kidney and gall bladder stones to drive the demand for ESWL
    • TABLE 38 ESWL ULTRASOUND MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.6 ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 39 ESWL ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • 6.3.7 ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 40 ESWL ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • 6.3.8 ESWL ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 41 ESWL ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 6.3.9 ESWL ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 42 ESWL ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 6.3.10 HIGH-INTENSITY FOCUSED ULTRASOUND
      • 6.3.10.1 Promising results associated with HIFU for the treatment of various cancers to drive market growth
    • TABLE 43 HIFU ULTRASOUND MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.11 HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 44 HIFU ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • 6.3.12 HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 45 HIFU ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • 6.3.13 HIFU ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 46 HIFU ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • 6.3.14 HIFU ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • TABLE 47 HIFU ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)

7 ULTRASOUND MARKET, BY SYSTEM PORTABILITY

  • 7.1 INTRODUCTION
    • TABLE 48 ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
  • 7.2 TROLLEY/CART-BASED DEVICES
    • 7.2.1 INCREASED USE OF TROLLEY-BASED SYSTEMS FOR ACUTE CARE & EMERGENCY CARE TO DRIVE MARKET GROWTH
    • TABLE 49 ULTRASOUND MARKET FOR TROLLEY/CART-BASED DEVICES, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 COMPACT/TABLE-TOP DEVICES
    • 7.3.1 DEVICE AFFORDABILITY AS WELL AS PROCEDURAL & TECHNICAL BENEFITS TO DRIVE THE DEMAND FOR TABLE-TOP DEVICES
    • TABLE 50 ULTRASOUND MARKET FOR COMPACT/TABLE-TOP DEVICES, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 POC/PORTABLE DEVICES
    • 7.4.1 IMPROVED OPERATIONAL AND CLINICAL EFFICACY TO BOOST THE DEMAND FOR POC ULTRASOUND DEVICES
    • TABLE 51 ULTRASOUND MARKET FOR POC/PORTABLE DEVICES, BY REGION, 2019-2026 (USD MILLION)

8 ULTRASOUND MARKET, BY DISPLAY TYPE

  • 8.1 INTRODUCTION
    • TABLE 52 ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
  • 8.2 COLOR ULTRASOUND DEVICES
    • 8.2.1 GREATER MARKET AVAILABILITY OF ADVANCED COLOR ULTRASOUND DEVICES TO DRIVE THE MARKET
    • TABLE 53 COLOR ULTRASOUND DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 BLACK & WHITE ULTRASOUND DEVICES
    • 8.3.1 ASIA PACIFIC REGION TO REGISTER SUSTAINED DEMAND FOR B/W ULTRASOUND DEVICES
    • TABLE 54 BLACK & WHITE ULTRASOUND DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)

9 ULTRASOUND MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 55 ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 9.2 RADIOLOGY/GENERAL IMAGING APPLICATIONS
    • 9.2.1 GROWING NUMBER OF IMAGE-GUIDED SURGERIES/RADIOLOGY PROCEDURES TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
    • TABLE 56 ULTRASOUND MARKET FOR RADIOLOGY/GENERAL IMAGING APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 CARDIOLOGY APPLICATIONS
    • 9.3.1 RISING PREVALENCE OF CARDIAC DISORDERS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
    • TABLE 57 ULTRASOUND MARKET FOR CARDIOLOGY APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 9.4 OBSTETRICS/GYNECOLOGY APPLICATIONS
    • 9.4.1 ULTRASOUND IS WIDELY USED IN THE FIELD OF OBSTETRICS AND GYNECOLOGY
    • TABLE 58 ULTRASOUND MARKET FOR OBSTETRICS/GYNECOLOGY APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 9.5 VASCULAR APPLICATIONS
    • 9.5.1 VASCULAR APPLICATIONS SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
    • TABLE 59 ULTRASOUND MARKET FOR VASCULAR APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 9.6 UROLOGICAL APPLICATIONS
    • 9.6.1 ULTRASOUND IS WIDELY USED IN THE DIAGNOSIS AND TREATMENT OF VARIOUS UROLOGICAL DISORDERS
    • TABLE 60 ULTRASOUND MARKET FOR UROLOGICAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 9.7 ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS
    • 9.7.1 RISING PATIENT PREFERENCE FOR EFFECTIVE & EARLY DISEASE DIAGNOSIS TO DRIVE THE GROWTH OF THIS APPLICATION SEGMENT
    • TABLE 61 ULTRASOUND MARKET FOR ORTHOPEDIC AND MUSCULOSKELETAL APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 9.8 PAIN MANAGEMENT APPLICATIONS
    • 9.8.1 ULTRASOUND DEVICES ARE INCREASINGLY BEING UTILIZED FOR TRAUMA & EMERGENCY CARE APPLICATIONS
    • TABLE 62 ULTRASOUND MARKET FOR PAIN MANAGEMENT APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 9.9 OTHER APPLICATIONS
    • TABLE 63 ULTRASOUND MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

10 ULTRASOUND MARKET, BY COMPONENT

  • 10.1 INTRODUCTION
    • TABLE 64 ULTRASOUND MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
  • 10.2 TRANSDUCERS/PROBES
    • TABLE 65 TRANSDUCERS/PROBES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 66 TRANSDUCERS/PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 10.2.1 CURVILINEAR/CONVEX ARRAY PROBES
      • 10.2.1.1 Growing adoption of POC ultrasound to drive the growth of this market segment
    • TABLE 67 CURVILINEAR/CONVEX ARRAY PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 10.2.2 LINER ARRAY PROBES
      • 10.2.2.1 Increasing target patient population to drive the growth of this market segment
    • TABLE 68 LINEAR ARRAY PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 10.2.3 PHASED ARRAY PROBES
      • 10.2.3.1 Technological advancements to drive the growth of this market segment
    • TABLE 69 PHASED ARRAY PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 10.2.4 OTHER PROBES
    • TABLE 70 OTHER PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.3 WORKSTATIONS
    • 10.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
    • TABLE 71 WORKSTATIONS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.4 OTHER COMPONENTS
    • TABLE 72 OTHER COMPONENTS MARKET, BY REGION, 2019-2026 (USD MILLION)

11 ULTRASOUND MARKET, BY END USER

  • 11.1 INTRODUCTION
    • TABLE 73 ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 11.2 HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS
    • 11.2.1 SIGNIFICANT NUMBER OF ULTRASOUND-BASED MEDICAL PROCEDURES ARE PERFORMED IN THESE FACILITIES
    • TABLE 74 ULTRASOUND MARKET FOR HOSPITALS, SURGICAL CENTERS, AND DIAGNOSTIC CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 11.3 MATERNITY CENTERS
    • 11.3.1 INCREASED ADOPTION OF ADVANCED 3D, 4D, AND DOPPLER ULTRASOUND FOR OB/GYN APPLICATIONS TO DRIVE MARKET GROWTH
    • TABLE 75 ULTRASOUND MARKET FOR MATERNITY CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 11.4 AMBULATORY CARE CENTERS
    • 11.4.1 GROWING NUMBER OF MINIMALLY INVASIVE PROCEDURES PERFORMED AT AMBULATORY CARE CENTERS TO DRIVE MARKET GROWTH
    • TABLE 76 ULTRASOUND MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 11.5 RESEARCH AND ACADEMIA
    • 11.5.1 GROWING RESEARCH GRANTS AND FUNDING TO DRIVE THE GROWTH OF THIS END-USER SEGMENT
    • TABLE 77 ULTRASOUND MARKET FOR RESEARCH AND ACADEMIA, BY REGION, 2019-2026 (USD MILLION)
  • 11.6 OTHER END USERS
    • FIGURE 29 NUMBER OF SPORTS INJURIES (2020)
    • TABLE 78 ULTRASOUND MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)

12 ULTRASOUND MARKET, BY REGION

  • 12.1 INTRODUCTION
    • TABLE 79 ULTRASOUND MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 12.2 EUROPE
    • FIGURE 30 EUROPE: ULTRASOUND MARKET SNAPSHOT
    • TABLE 80 EUROPE: ULTRASOUND MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 81 EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 82 EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 83 EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 84 EUROPE: ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 EUROPE: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 86 EUROPE: ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 87 EUROPE: ULTRASOUND MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 88 EUROPE: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 89 EUROPE: ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 12.2.1 GERMANY
      • 12.2.1.1 Wide acceptance of advanced technologies and favorable reimbursement scenario to drive market growth
    • TABLE 90 GERMANY: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 91 GERMANY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 92 GERMANY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.2.2 UK
      • 12.2.2.1 Rising geriatric population to drive market growth in the UK
    • TABLE 93 UK: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 94 UK: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 95 UK: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.2.3 FRANCE
      • 12.2.3.1 Modernization of healthcare infrastructure fueling the demand for ultrasound systems
    • TABLE 96 FRANCE: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 97 FRANCE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 98 FRANCE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.2.4 ITALY
      • 12.2.4.1 Improved reimbursement scenario and increasing R&D to support overall market growth
    • TABLE 99 ITALY: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 100 ITALY: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 101 ITALY: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.2.5 SPAIN
      • 12.2.5.1 Low entry barriers to create opportunities for global players to expand their presence in the country
    • TABLE 102 SPAIN: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 103 SPAIN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 SPAIN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.2.6 REST OF EUROPE
    • TABLE 105 REST OF EUROPE: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 106 REST OF EUROPE: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 107 REST OF EUROPE: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 12.3 NORTH AMERICA
    • TABLE 108 NORTH AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 109 NORTH AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 110 NORTH AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 111 NORTH AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 112 NORTH AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 113 NORTH AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 114 NORTH AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 115 NORTH AMERICA: ULTRASOUND MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 116 NORTH AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 NORTH AMERICA: ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 12.3.1 US
      • 12.3.1.1 The US dominated the North American ultrasound market
    • TABLE 118 POCUS ULTRASOUND CPT CODES (2021)
    • TABLE 119 CPT CODES FOR ULTRASOUND-GUIDED PROCEDURES (2021)
    • TABLE 120 US: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 121 US: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 122 US: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.3.2 CANADA
      • 12.3.2.1 Growing awareness about early disease diagnosis to drive market growth in Canada
    • TABLE 123 CANADA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 124 CANADA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 125 CANADA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 31 ASIA PACIFIC: ULTRASOUND MARKET SNAPSHOT
    • TABLE 126 ASIA PACIFIC: ULTRASOUND MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 128 ASIA PACIFIC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 ASIA PACIFIC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 ASIA PACIFIC: ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 131 ASIA PACIFIC: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 132 ASIA PACIFIC: ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: ULTRASOUND MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 134 ASIA PACIFIC: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 12.4.1 CHINA
      • 12.4.1.1 Increasing patient pool and localized manufacturing to drive the market growth
    • TABLE 136 CHINA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 137 CHINA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 138 CHINA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.4.2 JAPAN
      • 12.4.2.1 Rising geriatric population to boost market growth in Japan
    • TABLE 139 JAPAN: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 140 JAPAN: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 141 JAPAN: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.4.3 INDIA
      • 12.4.3.1 Significant burden of target diseases and availability of affordable devices to drive market growth
    • TABLE 142 INDIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 143 INDIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 144 INDIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.4.4 SOUTH KOREA
      • 12.4.4.1 Supportive government initiatives in the country to positively impact market growth
    • TABLE 145 SOUTH KOREA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 146 SOUTH KOREA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 147 SOUTH KOREA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.4.5 AUSTRALIA
      • 12.4.5.1 Growing research investments and awareness campaigns to drive market growth in Australia
    • TABLE 148 AUSTRALIA: ULTRASOUND REIMBURSEMENT SCENARIO
    • TABLE 149 AUSTRALIA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 150 AUSTRALIA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 151 AUSTRALIA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.4.6 REST OF ASIA PACIFIC
    • TABLE 152 ROAPAC: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 153 ROAPAC: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 154 ROAPAC: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 12.5 LATIN AMERICA
    • TABLE 155 LATIN AMERICA: ULTRASOUND MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 156 LATIN AMERICA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 157 LATIN AMERICA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 158 LATIN AMERICA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 159 LATIN AMERICA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 160 LATIN AMERICA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 161 LATIN AMERICA: ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 162 LATIN AMERICA: ULTRASOUND MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 163 LATIN AMERICA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 164 LATIN AMERICA: ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 12.5.1 BRAZIL
      • 12.5.1.1 Universal healthcare system to play a pivotal role in driving the use of ultrasound for disease diagnosis
    • TABLE 165 BRAZIL: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 166 BRAZIL: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 167 BRAZIL: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.5.2 MEXICO
      • 12.5.2.1 Modernization of healthcare infrastructure to support market growth in Mexico
    • TABLE 168 MEXICO: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 169 MEXICO: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 170 MEXICO: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 12.5.3 REST OF LATIN AMERICA
    • TABLE 171 ROLA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 172 ROLA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 173 ROLA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 12.6 MIDDLE EAST & AFRICA
    • 12.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA REGION
    • TABLE 174 MEA: ULTRASOUND MARKET, BY TECHNOLOGY, 2019-2026 (USD MILLION)
    • TABLE 175 MEA: DIAGNOSTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 176 MEA: THERAPEUTIC ULTRASOUND MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 177 MEA: ULTRASOUND MARKET, BY DISPLAY TYPE, 2019-2026 (USD MILLION)
    • TABLE 178 MEA: ULTRASOUND MARKET, BY SYSTEM PORTABILITY, 2019-2026 (USD MILLION)
    • TABLE 179 MEA: ULTRASOUND MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 180 MEA: ULTRASOUND MARKET, BY COMPONENT, 2019-2026 (USD MILLION)
    • TABLE 181 MEA: ULTRASOUND MARKET FOR TRANSDUCERS/PROBES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 182 MEA: ULTRASOUND MARKET, BY END USER, 2019-2026 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 KEY PLAYER STRATEGIES
    • FIGURE 32 KEY DEVELOPMENTS IN THE ULTRASOUND MARKET (2018 TO 2021)
  • 13.3 REVENUE SHARE ANALYSIS
    • FIGURE 33 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ULTRASOUND MARKET
  • 13.4 MARKET SHARE ANALYSIS: ULTRASOUND MARKET, BY KEY PLAYER (2020)
    • FIGURE 34 GE HEALTHCARE HELD THE LEADING POSITION IN THE ULTRASOUND MARKET IN 2020
    • TABLE 183 ULTRASOUND MARKET: DEGREE OF COMPETITION
  • 13.5 COMPANY EVALUATION QUADRANT FOR 25 KEY PLAYERS (2020)
    • 13.5.1 TERMINOLOGY/NOMENCLATURE
      • 13.5.1.1 Stars
      • 13.5.1.2 Emerging leaders
      • 13.5.1.3 Pervasive players
      • 13.5.1.4 Participants
    • FIGURE 35 ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
  • 13.6 COMPANY EVALUATION QUADRANT FOR START-UP/SMES (2020)
    • 13.6.1 PROGRESSIVE COMPANIES
    • 13.6.2 RESPONSIVE COMPANIES
    • 13.6.3 DYNAMIC COMPANIES
    • 13.6.4 STARTING BLOCKS
    • FIGURE 36 ULTRASOUND MARKET: COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS)
  • 13.7 COMPETITIVE BENCHMARKING
    • TABLE 184 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ULTRASOUND MARKET
  • 13.8 COMPETITIVE SCENARIO (2018-2021)
    • 13.8.1 NEW PRODUCT LAUNCHES AND APPROVALS
    • TABLE 185 ULTRASOUND MARKET: NEW PRODUCT LAUNCHES AND APPROVALS, 2018-2021
    • 13.8.2 DEALS
    • TABLE 186 ULTRASOUND MARKET: DEALS, 2018-2021
    • 13.8.3 EXPANSIONS
    • TABLE 187 ULTRASOUND MARKET: EXPANSIONS, 2018-2021

14 COMPANY PROFILES

  • 14.1 INTRODUCTION
  • 14.2 KEY PLAYERS
  • (Business overview, Products offered, Recent developments, MNM view)**
    • 14.2.1 GE HEALTHCARE
    • TABLE 188 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2020)
    • 14.2.2 KONINKLIJKE PHILIPS N.V.
    • TABLE 189 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 38 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020)
    • 14.2.3 CANON MEDICAL SYSTEMS CORPORATION
    • TABLE 190 CANON MEDICAL SYSTEMS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 39 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2020)
    • 14.2.4 SIEMENS AG
    • TABLE 191 SIEMENS AG: BUSINESS OVERVIEW
    • FIGURE 40 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
    • 14.2.5 HITACHI, LTD.
    • TABLE 192 HITACHI, LTD.: BUSINESS OVERVIEW
    • FIGURE 41 HITACHI, LTD.: COMPANY SNAPSHOT
    • 14.2.6 HOLOGIC, INC.
    • TABLE 193 HOLOGIC, INC.: BUSINESS OVERVIEW
    • FIGURE 42 HOLOGIC, INC.: COMPANY SNAPSHOT
    • 14.2.7 FUJIFILM HOLDINGS CORPORATION
    • TABLE 194 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 43 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
    • 14.2.8 SAMSUNG ELECTRONICS CO., LTD.
    • TABLE 195 SAMSUNG ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
    • FIGURE 44 SAMSUNG ELECTRONICS CO., LTD.: COMPANY SNAPSHOT
    • 14.2.9 MINDRAY MEDICAL INTERNATIONAL LIMITED
    • TABLE 196 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW
    • FIGURE 45 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT
    • 14.2.10 ANALOGIC CORPORATION
    • TABLE 197 ANALOGIC CORPORATION: BUSINESS OVERVIEW
    • 14.2.11 ESAOTE SPA
    • TABLE 198 ESAOTE S.P.A: BUSINESS OVERVIEW
    • 14.2.12 CARESTREAM HEALTH
    • TABLE 199 CARESTREAM HEALTH: BUSINESS OVERVIEW
    • FIGURE 46 ONEX CORPORATION: COMPANY SNAPSHOT
    • 14.2.13 CURA HEALTHCARE
    • TABLE 200 CURA HEALTHCARE: BUSINESS OVERVIEW
    • 14.2.14 CHISON MEDICAL TECHNOLOGIES CO., LTD.
    • TABLE 201 CHISON MEDICAL TECHNOLOGIES CO., LTD.: BUSINESS OVERVIEW
  • *Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies.
  • 14.3 OTHER COMPANIES
    • 14.3.1 MOBISANTE, INC.
    • 14.3.2 NEUSOFT CORPORATION
    • 14.3.3 CLARIUS MOBILE HEALTH
    • 14.3.4 MEDGYN PRODUCTS, INC.
    • 14.3.5 UNITED IMAGING HEALTHCARE CO., LTD.
    • 14.3.6 PROMED TECHNOLOGY CO., LTD.
    • 14.3.7 CEPHASONICS
    • 14.3.8 UAB TELEMED
    • 14.3.9 SHENZHEN RICSO TECHNOLOGY CO., LTD.
    • 14.3.10 WUHAN YOUKEY BIO-MEDICAL ELECTRONICS CO., LTD.

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 AVAILABLE CUSTOMIZATIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS